BioSante Pharmaceuticals (NASDAQ: BPAX) $2.27 -1.74% announced positive safety data in its ongoing LibiGel Phase III clinical development program. Company reported that with 2,869 women enrolled and over 3,000 women-years of exposure in its LibiGel Phase III cardiovascular and breast cancer safety study, there have been 17 adjudicated cardiovascular events, with a lower than anticipated event rate of ~0.57%. There have been eight breast cancers reported, a rate of ~0.27%. Therefore, the Phase III LibiGel safety study will continue as per the FDA-agreed protocol, without modifications including continued enrollment of new subjects.
BioSante Pharmaceuticals, Inc. (BioSante) is a specialty pharmaceutical company focused on developing products for female sexual health, menopause, contraception and male hypogonadism. The Company's products for female sexual health, menopause, contraception and male hypogonadism include LibiGel, a once daily transdermal testosterone gel in Phase III clinical development under a special protocol assessment (SPA) for the treatment of female sexual dysfunction (FSD); Elestrin, a once daily transdermal estradiol (estrogen) gel indicated for the treatment of moderate-to-severe vasomotor symptoms; The Pill-Plus (triple component contraceptive), a once daily use of various combinations of estrogens, progestogens and androgens in development for the treatment of female sexual dysfunction (FSD) in women using oral or transdermal contraceptives, and Bio-T-Gel, a once daily transdermal testosterone gel in development for the treatment of hypogonadism, or testosterone deficiency, in men.
Samson Oil & Gas (AMEX: SSN) $2.63 + 0.39%, advised that firm fracture stimulation dates for the Rodney #1-14H and Earl 1-13H wells have been established. Fracture stimulation operations are expected to commence March 14th for the Rodney well and March 28th for the Earl well. Company had anticipated this to take place in February. These two wells are the latest wells drilled to date in the North Stockyard field. Both wells are expected to start drilling in 2011.
Samson Oil & Gas Limited (Samson) is engaged in exploration and development of oil and natural gas properties in the United States. As of June 30, 2010, it had five material producing oil and gas properties. It does not operate any of its material, producing properties; rather, it owns a working interest in each property and has entered into operating agreements with third parties, under which the oil and gas are produced and sold.
BGC Partners Inc. (NASDAQ: BGCP) $9.05 +3.89%, announced its first full electronic Australian dollar interest rate swap trade using BGC's award-winning volume match tool on the BGC trader platform. The stock has been in an uptrend breaking its 52-week high yesterday of $9.06 with an increased volume of 730,000 shares.
BGC Partners, Inc. is a global financial intermediary to the financial markets specializing in the brokering of a range of financial products, including fixed income securities, interest rate swaps, foreign exchange, equities, equity derivatives, credit derivatives, commodities, futures, structured products and other instruments. It also provides a range of services, including trade execution, broker-dealer services, clearing, processing, information, and other back office services, to a range of financial and non-financial institutions.
Mentor Graphics Corporation (NASDAQ: MENT) $14.30 -0.14%, has announced that mediaTek has adopted the Calibre PERC product as solution for electrical rule checking to help ensure comprehensive electrostatic discharge protection and increase overall product reliability
Mentor Graphics Corporation is a provider of software and hardware design solutions that enable its customers to develop electronic products. The Company markets its products and services worldwide, primarily to large companies in the military/aerospace, communications, computer, consumer electronics, semiconductor, networking, multimedia, and transportation industries. The electronic systems that its customers create with its products include printed circuit boards, integrated circuits (ICs), field programmable gate arrays (FPGAs), embedded software solutions and wire harness systems.
Tower Semiconductor Ltd. (NASDAQ: TSEM) $1.41 +2.13%, reported earnings of $0.14 per share, in-line with the Thomson Reuters consensus of $0.14; revenues rose 34.3% year to year to $135.1 mln versus the $135 mln consensus. Company issued downside guidance for Q1, sees Q1 revs of $120-125 mln versus $131.40 mln Thomson Reuters consensus.
Tower Semiconductor Ltd. is an independent specialty foundry dedicated to the manufacture of semiconductors. Tower manufactures semiconductor using production processes for its customers based on third party designs and its own designs. It offers the manufacture of integrated circuits (ICs) with geometries ranging from 1.0 to 0.13-micron. Tower also provides design services and complementary technical services.
OTCPicks.com is not a
registered investment advisers or broker/dealer. OTCPicks.com makes no
recommendation that the purchase of securities of companies profiled in this
website is suitable or advisable for any person or that an investment such
securities will be profitable. In general, given the nature of the companies
profiled and the lack of an active trading market their securities, investing
in such securities is highly speculative and carries a high degree of risk.
Always do you own homework before investing in any stock.
Forward-Looking Statement: This press release includes "forward-looking statements" within the meaning of the federal securities laws, commonly identified by such terms as "believes," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Important factors that could cause actual results to differ materially from the Company's projections and expectations are disclosed in the Company's filings with the Securities and Exchange Commission. All forward-looking statements in this press release are expressly qualified by such cautionary statements and by reference to the underlying assumptions.
Disclosure: OTCpicks.com has not been compensated for any stocks listed in this stock news report
